Physician

Anita Louise Goodrich, MD

According to 2025 Medicare claims, Anita Goodrich, MD (NPI: 1356444509) practices dermatology in the Burlington-South Burlington, VT market, with the plurality of this provider's patient population coming from Chittenden, VT. This provider's primary affiliated billing organization is GREEN MOUNTAIN DERMATOLOGY PLLC (NPI: 1093577827; TIN: 853348644) and primary practice location at 05446-5988.

Goodrich's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 931 traditional Medicare patients, billed 4,023 HCPCS/CPT codes, and received $159,217 in Medicare payments. The top billing code was 17110 (Destruction of skin growth, 1-14 growths). Part D data shows 756 prescription claims across 354 beneficiaries totaling $524,912 in drug costs, led by Stelara (Ustekinumab). No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $226,981 to $159,217. In contrast, Part D prescription costs have moved sharply higher in recent years, from $163,204 to $524,912. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$142K$283K2015 Medicare payment: $226,981 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $283,264 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $230,847 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $243,574 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $261,034 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $189,160 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $213,768 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $171,883 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $167,349 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $159,217 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,3665,503$226,981
20161,6446,830$283,264
20171,5036,287$230,847
20181,6066,427$243,574
20191,6076,919$261,034
20201,1744,962$189,160
20211,1565,003$213,768
20229944,294$171,883
20239744,008$167,349
20249314,023$159,217

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$262K$525K2015 Drug cost: $163,204 (USD; Tot_Drug_Cst)2016 Drug cost: $129,391 (USD; Tot_Drug_Cst)2017 Drug cost: $144,707 (USD; Tot_Drug_Cst)2018 Drug cost: $162,881 (USD; Tot_Drug_Cst)2019 Drug cost: $195,167 (USD; Tot_Drug_Cst)2020 Drug cost: $201,088 (USD; Tot_Drug_Cst)2021 Drug cost: $248,651 (USD; Tot_Drug_Cst)2022 Drug cost: $363,357 (USD; Tot_Drug_Cst)2023 Drug cost: $492,857 (USD; Tot_Drug_Cst)2024 Drug cost: $524,912 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015304780$163,204
2016353843$129,391
2017333748$144,707
2018385793$162,881
2019402888$195,167
2020374896$201,088
2021393841$248,651
2022315738$363,357
2023324728$492,857
2024354756$524,912

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17110Destruction of skin growth, 1-14 growths217250$73
11102Biopsy of related skin growth, first growth203228$57
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more8061,055$55
17000Destruction of precancer skin growth, 1 growth318404$34
17003Destruction of precancer skin growth, 2-14 growths2171,144$5

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
StelaraUstekinumab131,122$174,998
OtezlaApremilast29870$139,894
CalcipotrieneCalcipotriene33870$5,076
FluorouracilFluorouracil621,750$3,970
Clobetasol PropionateClobetasol Propionate772,343$3,158

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

FAQ

What Medicare data is available for Anita Louise Goodrich, MD?

Tedicare shows public-source Medicare data for Anita Louise Goodrich, MD (NPI 1356444509), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Anita Louise Goodrich, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Anita Louise Goodrich, MD?

Anita Louise Goodrich, MD is linked to GREEN MOUNTAIN DERMATOLOGY PLLC (billing NPI 1093577827) in the available physician profile data.

Does Anita Louise Goodrich, MD have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.